EGFR and non-small cell lung carcinoma: Therefore, we conducted this retrospective real‐world study to compare first‐line clinical outcomes of chemotherapy alone, chemotherapy plus ICI, or chemotherapy plus Ai in advanced NSCLC patients with EGFR ex20ins.